No abstract available
Keywords:
meta-analysis; obesity; overweight; randomized controlled trials; semaglutide.
Publication types
-
Letter
-
Meta-Analysis
-
Systematic Review
MeSH terms
-
Diabetes Mellitus, Type 2* / drug therapy
-
Glucagon-Like Peptides / adverse effects
-
Humans
-
Hypoglycemic Agents / adverse effects
-
Obesity / drug therapy
-
Overweight* / complications
-
Overweight* / drug therapy
Substances
-
Hypoglycemic Agents
-
semaglutide
-
Glucagon-Like Peptides